The burgeoning landscape of innovative treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual mode agonists targeting the GLP-1 and GIP receptors. While sharing a alike https://mariamhnob223612.wikipowell.com/6761725/retatrutide_vs_tirzepatide_a_comparative_analysis